Comparative Study of Lidocaine and Palonosetron Pretreatment in Reduction of Propofol Induced Injection Pain
Journal Title: Journal of Clinical and Diagnostic Research - Year 2018, Vol 12, Issue 6
Abstract
ABSTRACT Introduction: Propofol is very popular as an induction agent in modern day anaesthesia because of its favourable pharmacodynamics and fewer side effects. Any pain pre or post-anaesthesia leads to patient dissatisfaction. The incidence of pain during propofol induction is almost 70%. Aim: To compare palanosetron and lidocaine to each other as well as with the control group receiving normal saline as placebo in decreasing propofol induced injection pain and to compare patient satisfaction in both the test groups. Materials and Methods: A total of 150 patients were randomised to constitute three groups. Group L who received 0.5 mg/kg of 2% lidocaine, Group P received palonosetron 0.075 mg, and Group N who received normal saline 0.9% constituted the control group. Patients were given a 5 mL pretreatment solution, containing either lignocaine 0.5 mg/kg, palonosetron 0.075 mg or 0.9% normal saline intravenously. Following pretreatment, venous drainage was occluded at midarm level with a tourniquet. Tourniquet was released after one minute. Propofol injection was given over five seconds at 25% of the total calculated induction dose. Patients were then interviewed about the magnitude of pain and rated as per a pain scale. Descriptive statistics such as range, mean, Standard Deviation (SD) were used to summarise the baseline clinical and demographic profile of the patients. Chi-square test was performed for comparison of categorical data. Results: Both the study drugs i.e., lidocaine and palonosetron caused significant reduction in pain as compared to the placebo (normal saline) group. Only 20% of patients had pain free induction (at five seconds) in saline group as compared to 64% and 70% in Groups P and L respectively. Comparison among three groups was highly significant with p<0.001. Conclusion: Palonosetron was almost as effective as lidocaine in reducing propofol induced injection pain. Palonosetron has an added advantage because of its antiemetic property so can be chosen as an alternative to lidocaine.
Authors and Affiliations
Suruchi Ambasta, Swagat Mahapatra
Keywords
Related Articles
- EP ID EP525858
- DOI 10.7860/JCDR/2018/34596.11691
- Views 87
- Downloads 0
Nephroprotective Effect of Ethanolic Extract of Flax Seed
ABSTRACT Introduction: The treatment of Acute Kidney Injury (AKI) remains empirical and hence the quest for an effective agent for this condition still remains a challenge. The nephroprotective effect of flax seeds has b...
Assessment of Osteoporotic Alterations in Brazilian Postmenopausal Women: A Retrospective Study
ABSTRACT Introduction: Peripheral Dual X-Ray Absorptiometry (DXA) has been recognized as convenient to assess Bone Mass Density (BMD) and fracture risk. Nevertheless, DXA is not largely available mainly in developing cou...
Multidisciplinary Clinical Management of Paraneoplastic Pemphigus – A Case Report
Paraneoplastic pemphigus is a rare immunobullous disorder commonly associated with lymphoproliferative neoplasms and less commonly in carcinomas with a poor prognosis. The neoplasms produce autoantibodies that react with...
Protein Creatinine Index: An Alternative for Screening Nephropathy in Hypertensives
ABSTRACT Introduction: The 24 hour urinary protein estimation is the gold standard for detecting proteinuria and nephropathy in hypertensives. But, it’s a time-consuming and inconvenient process. Aim: To analyse the util...
Immunopathological Concepts Behind Autoimmunity
ABSTRACT Autoimmunity is the failure of self-tolerance of an organism, which empowers immune response against its own cells and tissues generating autoimmune diseases. Autoimmune diseases are exceeding 100 million peopl...